Human targeted phenobarbital presents a poor substrate of gut microbiome deciphering new drug targets beyond pharmacokinetic curbs
The gut microbiome, a new organ of the body, can potentially alter the pharmacokinetics of orally administered drugs through microbial enzymes. However, absorption of orally administered non-antibiotic drugs b...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Imran Mukhtar, Haseeb Anwar, Arslan Iftikhar, Heba E. Hashem, Qasim Ali and Farhan Siddique Tags: Research Source Type: research
More News: Drugs & Pharmacology | Phenobarbital